Search research articles
Contact Us
Filters
Showing results (21-30 of 83) with videos related to
Page
of 9
Sort By:
Journal of Neuroscience Research
|
March 1, 1992
Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism
R Hellweg, R Nitsch, C Hock, et al.
Acta Chirurgica Hungarica
|
January 1, 1992
The technique of obtaining pancreatic segments in dogs: surgical-anatomical aspects
I Mikó, I Furka, P Sápy, et al.
Journal of Psychiatric Research
|
May 1, 1996
The PHA-induced calcium signal in lymphocytes is altered after blockade of K(+)-channels in Alzheimer's disease
B Bondy, M Hofmann, F Müller-Spahn, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
CNS demyelination in monoclonal gammopathy of undetermined significance (MGUS): possible cause of a dementia syndrome
H Hampel, C Schneider, C Hock, et al.
Biological Psychiatry
|
July 1, 1999
A rapid-cycling bipolar patient treated with long nights, bedrest, and light
A Wirz-Justice, C Quinto, C Cajochen, et al.
Pharmacopsychiatry
|
July 1, 1995
Reduced beta-amyloid response in lymphocytes of patients with Alzheimer's disease
B Bondy, M Hofmann, F Müller-Spahn, et al.
Praxis
|
December 9, 2000
[Diagnosis and therapy of behavior disorders in dementia]
C Hock, A Wettstein, P Giannakopoulos, et al.
Neuroscience Letters
|
April 11, 1997
Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease
S Golombowski, F Müller-Spahn, H Romig, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
|
July 13, 2015
A comparison of tibial and peroneal venous and HePTFE bypasses in diabetics with critical limb ischemia
C Hock, T Betz, I Töpel, et al.
International Journal of Clinical Practice
|
September 26, 2002
Galantamine provides broad benefits in patients with 'advanced moderate' Alzheimer's disease (MMSE < or = 12) for up to six months
D G Wilkinson, C Hock, M Farlow, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 83) with videos related to
Sort By:
Page
of 9
Journal of Neuroscience Research
|
March 1, 1992
Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism
R Hellweg, R Nitsch, C Hock, et al.
Acta Chirurgica Hungarica
|
January 1, 1992
The technique of obtaining pancreatic segments in dogs: surgical-anatomical aspects
I Mikó, I Furka, P Sápy, et al.
Journal of Psychiatric Research
|
May 1, 1996
The PHA-induced calcium signal in lymphocytes is altered after blockade of K(+)-channels in Alzheimer's disease
B Bondy, M Hofmann, F Müller-Spahn, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 25, 2009
CNS demyelination in monoclonal gammopathy of undetermined significance (MGUS): possible cause of a dementia syndrome
H Hampel, C Schneider, C Hock, et al.
Biological Psychiatry
|
July 1, 1999
A rapid-cycling bipolar patient treated with long nights, bedrest, and light
A Wirz-Justice, C Quinto, C Cajochen, et al.
Pharmacopsychiatry
|
July 1, 1995
Reduced beta-amyloid response in lymphocytes of patients with Alzheimer's disease
B Bondy, M Hofmann, F Müller-Spahn, et al.
Praxis
|
December 9, 2000
[Diagnosis and therapy of behavior disorders in dementia]
C Hock, A Wettstein, P Giannakopoulos, et al.
Neuroscience Letters
|
April 11, 1997
Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease
S Golombowski, F Müller-Spahn, H Romig, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
|
July 13, 2015
A comparison of tibial and peroneal venous and HePTFE bypasses in diabetics with critical limb ischemia
C Hock, T Betz, I Töpel, et al.
International Journal of Clinical Practice
|
September 26, 2002
Galantamine provides broad benefits in patients with 'advanced moderate' Alzheimer's disease (MMSE < or = 12) for up to six months
D G Wilkinson, C Hock, M Farlow, et al.
Page
of 9